BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

482 related articles for article (PubMed ID: 32575762)

  • 1. How do Uremic Toxins Affect the Endothelium?
    Cunha RSD; Santos AF; Barreto FC; Stinghen AEM
    Toxins (Basel); 2020 Jun; 12(6):. PubMed ID: 32575762
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Indoxyl Sulfate, a Uremic Endotheliotoxin.
    Lano G; Burtey S; Sallée M
    Toxins (Basel); 2020 Apr; 12(4):. PubMed ID: 32260489
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The aryl hydrocarbon receptor-activating effect of uremic toxins from tryptophan metabolism: a new concept to understand cardiovascular complications of chronic kidney disease.
    Sallée M; Dou L; Cerini C; Poitevin S; Brunet P; Burtey S
    Toxins (Basel); 2014 Mar; 6(3):934-49. PubMed ID: 24599232
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Tryptophan-Derived Uremic Toxins and Thrombosis in Chronic Kidney Disease.
    Addi T; Dou L; Burtey S
    Toxins (Basel); 2018 Oct; 10(10):. PubMed ID: 30322010
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Impact of Uremic Toxins on Endothelial Dysfunction in Chronic Kidney Disease: A Systematic Review.
    Harlacher E; Wollenhaupt J; Baaten CCFMJ; Noels H
    Int J Mol Sci; 2022 Jan; 23(1):. PubMed ID: 35008960
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Aryl Hydrocarbon Receptor Activation in Chronic Kidney Disease: Role of Uremic Toxins.
    Brito JS; Borges NA; Esgalhado M; Magliano DC; Soulage CO; Mafra D
    Nephron; 2017; 137(1):1-7. PubMed ID: 28490014
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Uremic Toxins and Frailty in Patients with Chronic Kidney Disease: A Molecular Insight.
    Chao CT; Lin SH
    Int J Mol Sci; 2021 Jun; 22(12):. PubMed ID: 34200937
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Endothelial Damage, Inflammation and Immunity in Chronic Kidney Disease.
    Diaz-Ricart M; Torramade-Moix S; Pascual G; Palomo M; Moreno-Castaño AB; Martinez-Sanchez J; Vera M; Cases A; Escolar G
    Toxins (Basel); 2020 Jun; 12(6):. PubMed ID: 32492843
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Targeting Uremic Toxins to Prevent Peripheral Vascular Complications in Chronic Kidney Disease.
    Wu CL; Tarng DC
    Toxins (Basel); 2020 Dec; 12(12):. PubMed ID: 33419312
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Uremic Toxins and Vascular Calcification-Missing the Forest for All the Trees.
    Rapp N; Evenepoel P; Stenvinkel P; Schurgers L
    Toxins (Basel); 2020 Sep; 12(10):. PubMed ID: 33003628
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Contribution of Gut Microbiota-Derived Uremic Toxins to the Cardiovascular System Mineralization.
    Filipska I; Winiarska A; Knysak M; Stompór T
    Toxins (Basel); 2021 Apr; 13(4):. PubMed ID: 33920096
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Aryl Hydrocarbon Receptor and Uremic Toxins from the Gut Microbiota in Chronic Kidney Disease Patients: Is There a Relationship between Them?
    Brito JS; Borges NA; Anjos JSD; Nakao LS; Stockler-Pinto MB; Paiva BR; Cardoso-Weide LC; Cardozo LFMF; Mafra D
    Biochemistry; 2019 Apr; 58(15):2054-2060. PubMed ID: 30912928
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The Impact of Uremic Toxicity Induced Inflammatory Response on the Cardiovascular Burden in Chronic Kidney Disease.
    Claro LM; Moreno-Amaral AN; Gadotti AC; Dolenga CJ; Nakao LS; Azevedo MLV; de Noronha L; Olandoski M; de Moraes TP; Stinghen AEM; Pécoits-Filho R
    Toxins (Basel); 2018 Sep; 10(10):. PubMed ID: 30249039
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Immune Dysfunction in Uremia 2020.
    Cohen G
    Toxins (Basel); 2020 Jul; 12(7):. PubMed ID: 32635646
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Protein-bound uremic toxins: new culprits of cardiovascular events in chronic kidney disease patients.
    Ito S; Yoshida M
    Toxins (Basel); 2014 Feb; 6(2):665-78. PubMed ID: 24561478
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The kidney and uremic toxin removal: glomerulus or tubule?
    Masereeuw R; Mutsaers HA; Toyohara T; Abe T; Jhawar S; Sweet DH; Lowenstein J
    Semin Nephrol; 2014 Mar; 34(2):191-208. PubMed ID: 24780473
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The cardiovascular effect of the uremic solute indole-3 acetic acid.
    Dou L; Sallée M; Cerini C; Poitevin S; Gondouin B; Jourde-Chiche N; Fallague K; Brunet P; Calaf R; Dussol B; Mallet B; Dignat-George F; Burtey S
    J Am Soc Nephrol; 2015 Apr; 26(4):876-87. PubMed ID: 25145928
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The Interplay between Uremic Toxins and Albumin, Membrane Transporters and Drug Interaction.
    Cunha RSD; Azevedo CAB; Falconi CA; Ruiz FF; Liabeuf S; Carneiro-Ramos MS; Stinghen AEM
    Toxins (Basel); 2022 Feb; 14(3):. PubMed ID: 35324674
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Vascular incompetence in dialysis patients--protein-bound uremic toxins and endothelial dysfunction.
    Jourde-Chiche N; Dou L; Cerini C; Dignat-George F; Brunet P
    Semin Dial; 2011; 24(3):327-37. PubMed ID: 21682773
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Role of Uremic Toxins for Kidney, Cardiovascular, and Bone Dysfunction.
    Fujii H; Goto S; Fukagawa M
    Toxins (Basel); 2018 May; 10(5):. PubMed ID: 29772660
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 25.